Clinical Trials Directory

Trials / Unknown

UnknownNCT05662163

Effect of General Anesthesia Method on Cardiac Risk Patients on Ischemia Modified Markers

Effect of General Anesthesia Method Chosen in Non-cardiac Surgery of Cardiac Risk Patients on Ischemia Modified Albumin and Heart-Type Fatty Acid-Binding Protein (H-FABP) Levels

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Ataturk University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

To examine the effects of the general anesthesia method chosen in non-cardiac surgical operations of patients with cardiac risk on the levels of cardiac markers

Detailed description

To examine the effects of the general anesthesia method chosen in non-cardiac surgical operations of patients with cardiac risk on the levels of cardiac markers like; serum levels of the Creatine Kinase, Creatine Kinase Myocardial Band, high sensitive troponin, heart-type fatty acid-binding protein, ischemia-modified albumin and albumin. And evaluate the effect of anesthesia method on haemodynamic.

Conditions

Interventions

TypeNameDescription
PROCEDURETIVAAnesthesia will be maintained with propofol (6-10 mg/kg/hour) and remifentanil (0.1-0.3 μg/kg/min).
PROCEDUREGENERAL ANESTHESIAAnesthesia will be maintained with sevoflurane (2 ml/min) 50% oxygen and remifentanil (0.1-0.3 μg/kg/min).

Timeline

Start date
2022-12-30
Primary completion
2023-06-30
Completion
2023-12-30
First posted
2022-12-22
Last updated
2022-12-22

Source: ClinicalTrials.gov record NCT05662163. Inclusion in this directory is not an endorsement.